Clinical Trials on 心血管疾病的生物标志物 in Japan
总计1348个结果
-
Atsushi KawakamiAbbVie GK.招聘中
-
Atsushi KawakamiGilead Sciences招聘中类风湿关节炎 | 生物标志物 | JAK抑制剂 | 肌肉骨骼超声 | IL-6抑制剂日本
-
BayerJanssen Research & Development, LLC尚未招聘
-
Novo Nordisk A/S完全的
-
Kurashiki Central HospitalJapanese CTO PCI Expert Registry investigators招聘中
-
Kumamoto University完全的
-
University of ToyamaNational Cancer Center, Korea; Samsung Medical Center; Seoul National University Hospital; Seoul... 和其他合作者主动,不招人
-
Kyoto University, Graduate School of MedicineKyoto Prefectural University of Medicine撤销高血压 | 心血管疾病 | 血管疾病日本
-
Astellas Pharma Inc完全的
-
Seiji Umemoto, M.D., Ph.D.Yamaguchi University Hospital; The Japanese Society of Hypertension; Kyowa Hakko Kogyo Co., Ltd.完全的
-
UMN Pharma Inc.完全的健康 | Immunogenicity of ASP7374日本
-
Tokyo UniversityJapan Agency for Medical Research and Development完全的
-
Osaka UniversityMerck Sharp & Dohme LLC未知
-
GlaxoSmithKline完全的
-
BayerRegeneron Pharmaceuticals完全的
-
RS MedicalAccelerated Care Plus; Research Institute of Health and Science (RIHSE)完全的
-
Eli Lilly and CompanyShionogi完全的
-
Jichi Medical University完全的
-
Abbott Medical DevicesJapanese society of Congenital Interventional Cardiology招聘中